While mutations in the middle of the motif, common among the less frequent hotspots, should disrupt binding, ETS factors tend to be oncogenes that are activated in cancer [30], and it can be noted that TERT promoter mutations instead enable ETS binding through formation of TTCC elements [1, 2]. The gene discussed is TERT; the disease is cancer.